PCOS Patient-Focused Drug Development Meeting

PCOS Externally-Led Patient-Focused Drug Development Meeting (PCOS EL-PFDD) Presented by PCOS Challenge: The National Polycystic Ovary Syndrome Association.PCOS affects up to 15% of women and can lead to severe health issues, yet lacks FDA-approved treatments. The PCOS EL-PFDD Meeting is a pivotal listening session for the FDA and industry stakeholders to learn from patients about their needs and priorities for new treatments.Benefits for pharma/industry representatives attending:- Gain an in-depth understanding of patients' experiences and symptom burden- Learn factors influencing treatment choices and clinical trial participation- Drive more effective drug development by identifying unmet needs in PCOS care.Admission is free.